Decorin compositions and use thereof
AssigneeCatalent Pharma Solutions, LLC
InventorsGregory Thomas Bleck, Ian John Collins, Mark Joseph Frey
Life of this patent
Estimating the term…
Abstract
The present invention relates to improved decorin compositions and methods of their production.
Claims31
A fusion protein comprising a heterologous signal peptide operably linked to a sequence encoding decorin.
A method of producing a non-gagylated decorin core protein comprising:
- providing host cells expressing non-gagylated decorin core protein;
- culturing said host cell so that said non-gagylated decorin core protein is produced;
- and
- purifying said non-gagylated decorin core protein.
A method for purifying decorin from a decorin-containing medium comprising:
- contacting said decorin-containing medium with a cation exchange medium;
- washing said cation exchange medium;
- eluting a first decorin-containing eluate from said cation exchange medium;
- contacting said at first decorin-containing eluate with a hydroxyapatite medium;
- washing said hydroxyapatite medium;
- eluting a second decorin-containing eluate from said hydroxyapatite medium;
- filtering said second decorin-containing eluate with an ion exchange membrane to provide a decorin-containing filtrate;
- treating said filtrate to remove viruses;
- concentrating decorin from said filtrate.
A composition comprising a purified decorin core protein comprising a mutation at position 4 of the mature decorin core protein so that said decorin protein is substantially non-gagylated, said composition comprising less than about 100 ng residual host cell protein/mg decorin core protein in said composition and less than about 20 pg residual host cell DNA/mg decorin core protein.
Dependencies are inferred from the claim text.